Artificial Heart-Lung Machine Market Report by Type (Single Roller Pump, Double Roller Pump), Application (Cardiac Surgeries, Lung Surgeries, Acute Respiratory Failure Treatment, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, and Others), and Region 2025-2033

Artificial Heart-Lung Machine Market Report by Type (Single Roller Pump, Double Roller Pump), Application (Cardiac Surgeries, Lung Surgeries, Acute Respiratory Failure Treatment, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, and Others), and Region 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A1537

Market Overview:

The global artificial heart-lung machine market size reached USD 302.6 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 401.6 Million by 2033, exhibiting a growth rate (CAGR) of 3.04% during 2025-2033.

Report Attribute Key Statistics
Base Year
2024
Forecast Years
2025-2033
Historical Years
2019-2024
Market Size in 2024
USD 302.6 Million
Market Forecast in 2033
USD 401.6 Million
Market Growth Rate (2025-2033) 3.04%


An artificial heart-lung machine, also known as a cardiopulmonary bypass (CPB) or oxygenator pump, is used during coronary artery bypass, heart and lung transplants, and other cardiac surgeries. It temporarily performs the functions of the heart and lungs to enable the surgeon to operate in motion and bloodless surgical field. These machines consist of a chamber that receives blood, which is then oxygenated and circulated to all body parts. Over the years, these pumps have helped in making significant advances in the management of severe respiratory failure as well as in the field of car-diac surgeries.

In recent years, there has been a significant rise in the number of open-heart surgeries, heart transplants and lung surgeries across the globe. This can primarily be attributed to various environmental and lifestyle changes, which have led to an increase in the prevalence of cardiovascular diseases and the instances of organ failures. Other than this, governments of several developing nations are making efforts for providing improved healthcare facilities to patients, which is driving the demand for artificial heart-lung machines. Furthermore, the market players are investing in research and development activities to modernize the current models of oxygenator pumps. These activities have led to the development of modular heart-lung machines that are cost-effective, safe, and user-friendly in nature. Besides this, these machines also offer flexibility to doctors as they are portable and can be operated on rechargeable batteries. The manufacturers have also made several improvements in CPB pumps to prevent the over-oxygenation of blood. 

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global artificial heart-lung machine market report, along with forecasts at the global and regional level from 2025-2033. Our report has categorized the market based on type, application and end user.

Breakup by Type:

  • Single Roller Pump
  • Double Roller Pump
     

Breakup by Application:

  • Cardiac Surgeries
  • Lung Surgeries
  • Acute Respiratory Failure Treatment
  • Others
     

Breakup by End User:

  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Others
     

Breakup by Region:

Artificial Heart-Lung Machine Market Report

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America
     

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Medtronic Inc., Sorin Group, MAQUET GmbH & Co KG, Terumo Corporation, C.R. Bard Inc., Tianjin Welcome Medical Equipment Co., Ltd., Edwards Lifesciences, Jarvik Heart Inc., Braile Biomedica, SynCardia Systems, LLC, etc.

Report Coverage:

Report Features Details
Base Year of the Analysis 2024
Historical Period 2019-2024
Forecast Period 2025-2033
Units Million USD
Segment Coverage Type, Application, End User, Region
Region Covered Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Companies Covered Medtronic Inc., Sorin Group, MAQUET GmbH & Co KG, Terumo Corporation, C.R. Bard Inc., Tianjin Welcome Medical Equipment Co., Ltd., Edwards Lifesciences, Jarvik Heart Inc., Braile Biomedica and SynCardia Systems, LLC
Customization Scope 10% Free Customization
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Key Questions Answered in This Report

The global artificial heart-lung machine market was valued at USD 302.6 Million in 2024.

We expect the global artificial heart-lung machine market to exhibit a CAGR of 3.04% during 2025-2033.

The growing instances of organ failures and cardiovascular diseases, along with the rising focus towards providing advanced healthcare facilities to patients, are primarily driving the global artificial heart-lung machine market.

The sudden outbreak of the COVID-19 pandemic has led to the increasing utilization of artificial heart-lung machine in the management of severe respiratory failure and in the field of cardiac surgeries, to treat coronary and respiratory side-effects among the coronavirus-infected patients.

Based on the type, the global artificial heart-lung machine market can be segmented into single roller pump and double roller pump. Currently, single roller pump holds the majority of the total market share.

Based on the application, the global artificial heart-lung machine market has been divided into cardiac surgeries, lung surgeries, acute respiratory failure treatment, and others. Among these, cardiac surgeries currently exhibit a clear dominance in the market.

Based on the end user, the global artificial heart-lung machine market can be categorized into hospitals and clinics, ambulatory surgical centers, and others. Currently, hospitals and clinics account for the largest market share.

On a regional level, the market has been classified into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America, where North America currently dominates the global market.

Some of the major players in the global artificial heart-lung machine market include Medtronic Inc., Sorin Group, MAQUET GmbH & Co KG, Terumo Corporation, C.R. Bard Inc., Tianjin Welcome Medical Equipment Co., Ltd., Edwards Lifesciences, Jarvik Heart Inc., Braile Biomedica, SynCardia Systems, LLC, etc.

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Artificial Heart-Lung Machine Market Report by Type (Single Roller Pump, Double Roller Pump), Application (Cardiac Surgeries, Lung Surgeries, Acute Respiratory Failure Treatment, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, and Others), and Region 2025-2033
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials